FDA to Consult Advisory Panel About Additional COVID-19 Vaccine Boosters

A medical volunteer prepares the Moderna COVID-19 vaccine for a patient at Lestonnac Free Clinic in Orange, Calif., on March 9, 2021. John Fredricks/The Epoch Times

The Food and Drug Administration (FDA) plans to consult a panel of experts before clearing additional COVID-19 vaccine booster doses.

The current plan is “to gather our independent panel of outside experts next month to have a transparent discussion about considerations for 2022 booster shots, including whether and when those boosters may be needed and for which populations, based on the available data and latest science on circulating or emerging virus variant,” an FDA spokeswoman told The Epoch Times via email.